Pfizer retracts request for emergency approval of Covid-19 vaccine in India
Pfizer on Friday said that
it has withdrawn it's application for emergency use authorization for the Covid-19 vaccine in India.
The US
based drug major said that it would submit the additional information as it
becomes available in the near future,
The
company met the Subject Expert Committee (SEC) on February 3.
"Based
on the deliberations at the meeting and our understanding of additional
information that the regulator may need, the company has decided to withdraw
its application at this time. Pfizer will continue to engage with the authority
and resubmit its approval request with additional information as it becomes
available in the near future," a company spokesperson said.
The firm
had missed appearing before the SEC thrice before. It had said that short
notice and time zone difference were the reasons behind it.
Pfizer
has not conducted any bridge trial on Indian population for its mRNA vaccine.
The Indian regulator has asked foreign vaccine makers like Astrazeneca and
Russia's Sputnik V to conduct safety and immunogenicity trials on Indians. Read More
Comments
Post a Comment